The global single-use assemblies market is expanding rapidly as biopharmaceutical manufacturers increasingly adopt disposable fluid-handling systems to improve production flexibility, contamination control, and operational efficiency. Single-use assemblies are preassembled plastic fluid paths and self-contained products used across multiple stages of biopharmaceutical manufacturing, including filtration, cell culture, mixing, storage, sampling, and fill-finish operations. Their ability to reduce cleaning requirements, sterilization procedures, validation activities, and changeover times is encouraging pharmaceutical companies and contract manufacturers to transition from conventional stainless-steel systems toward disposable technologies. Growing biologics production, expanding cell and gene therapy pipelines, and increasing investment in bioprocessing infrastructure are further strengthening demand.

The global single-use assemblies market was valued at USD 15.0 billion in 2025 and is projected to reach USD 31.9 billion by 2030, expanding at a compound annual CAGR of 16.2% from 2025 to 2030. The market was estimated at USD 13.5 billion in 2024, highlighting the rapid expansion expected across biopharmaceutical manufacturing. North America dominated the market with a 37.2% revenue share in 2024, while Asia Pacific is projected to register the fastest CAGR of 19.5% from 2025 to 2030.

Download a free sample copy of the Single-use Assemblies Market report to understand detailed coverage and inclusions in the final report 

Key Market Segmentations

Product Type

• Filtration Assemblies: The filtration assemblies segment held the largest share of 28.9% of overall revenue in 2024. Increasing regulatory requirements and the need to reduce contamination risks are encouraging pharmaceutical manufacturers to use single-use filtration assemblies for bulk and final-fill operations. These systems provide a flexible alternative to stainless-steel equipment by eliminating several sterilization and validation procedures. 

• Bag Assemblies: The bag assemblies segment is expected to register the fastest CAGR during the forecast period. Single-use bags are increasingly used for cell cultivation, formulation, sampling, buffer and media preparation, feed processes, transportation, and bulk freezing. Their lower maintenance requirements, reduced capital investment, lightweight construction, and simplified handling are contributing to broader adoption. 

• Other Products: Bottle assemblies, tubing assemblies, and other disposable components also contribute to the market by supporting fluid management and integrated bioprocessing workflows.

Application

• Filtration: Filtration dominated the market in 2024, accounting for 28.9% of revenue. Single-use filtration systems can significantly reduce process time and simplify manufacturing operations because they are supplied ready to use. Their adoption is particularly important as biopharmaceutical manufacturers seek faster production cycles and greater flexibility across multiple products. 

• Cell Culture & Mixing: This segment is expected to record the fastest CAGR from 2025 to 2030. Growing demand for biopharmaceuticals, increasing R&D investments, and wider use of mammalian cell lines in upstream processing are creating strong opportunities for single-use cell culture and mixing systems. 

• Storage and Other Applications: Single-use assemblies are also increasingly used for storage, sampling, fill-finish applications, and other fluid-processing activities. These applications benefit from reduced cleaning requirements and greater operational flexibility.

Solution

• Customized Solutions: Customized solutions dominated the market with a 71.7% revenue share in 2024. Biopharmaceutical companies increasingly require assemblies configured around specific manufacturing workflows, component compatibility requirements, and process conditions. Custom systems can simplify integration while reducing the need for extensive sterilization and cleaning procedures. 

• Standard Solutions: Standard assemblies provide manufacturers with readily available configurations that can simplify procurement and implementation. These solutions remain relevant for facilities seeking standardized components and predictable manufacturing workflows.

End Use

• Biopharmaceutical & Pharmaceutical Companies: This segment dominated the market with a 49.5% revenue share in 2024. The expansion of biologics manufacturing facilities is increasing demand for disposable assemblies across upstream and downstream processes. Growing investment in biologics production, vaccines, and advanced therapies is expected to maintain the segment's leadership. 

• CROs & CMOs: CROs and CMOs are expected to register the highest CAGR during the forecast period. Contract manufacturers are increasingly incorporating single-use technologies to accelerate processing and changeovers while reducing operating expenses and capital investments. The flexibility of single-use systems is particularly valuable when facilities manufacture multiple products for different clients. 

• Academic & Research Institutes: Research organizations are also adopting single-use technologies because of their scalability, ease of implementation, and suitability for experimental and small-batch bioprocessing.

Core Market Dynamics

Growth Drivers

• Growing Biologics Production: Increasing demand for biologics, vaccines, and advanced therapies is one of the primary factors supporting the adoption of single-use assemblies. The rising prevalence of cancer and infectious diseases is encouraging pharmaceutical companies to develop and manufacture new biologic therapies, creating additional demand for flexible bioprocessing infrastructure. 

• Contamination Control: Single-use systems can reduce cross-contamination risks associated with reusable manufacturing equipment. Because disposable components can be replaced between production campaigns, manufacturers can simplify cleaning and sterilization requirements while improving process control.

• Operational Efficiency: Single-use assemblies eliminate or reduce several activities associated with traditional stainless-steel systems, including cleaning, sterilization, validation, and lengthy changeovers. This allows manufacturers to accelerate production and potentially lower operating and capital costs. 

• Growing CMO Adoption: Contract manufacturing organizations are increasingly using single-use technologies because they enable faster process changeovers and provide greater flexibility for multi-product manufacturing. This trend is creating significant opportunities for suppliers of customized disposable assemblies. 

Industry Challenges

• Regulatory Concerns: Extractables and leachables remain important considerations because materials used in disposable systems must meet stringent quality and safety requirements. Regulatory frameworks such as USP <665>, USP <1665>, and EU Annex 1 are increasing attention on material testing, documentation, traceability, and validation. 

• Waste Disposal: Greater adoption of disposable systems increases the volume of plastic waste generated by biopharmaceutical manufacturing. Manufacturers and suppliers therefore face growing pressure to improve sustainability, recycling, and waste-management practices.

• Component Standardization: Differences in connectors, tubing, bags, filters, and other components can create compatibility challenges. Greater standardization could make integration easier and reduce dependence on proprietary configurations.

Looking for more specific insights? Customize this report to suite your business needs

Regional Market Outlook

North America dominated the global single-use assemblies market with a 37.2% revenue share in 2024. Strong biotechnology and pharmaceutical industries, significant investments in drug discovery, advanced manufacturing infrastructure, and growing demand for biologics are supporting the region's leadership. The U.S. remains a major market due to its established biopharmaceutical ecosystem and increasing adoption of single-use technologies. 

Europe is supported by stringent regulatory frameworks, a strong biosimilars pipeline, increasing biomanufacturing automation, and investments in modular manufacturing facilities. Germany, the UK, and France are important markets, while growing adoption of advanced therapies is creating additional opportunities for single-use technologies. 

Asia Pacific is expected to be the fastest-growing regional market, registering a 19.5% CAGR from 2025 to 2030. Expanding biopharmaceutical manufacturing, government initiatives, local production investments, and increasing demand for vaccines and biologics are accelerating adoption. China, India, Japan, South Korea, Australia, and Thailand represent important markets across the region. 

Latin America is benefiting from gradual improvements in pharmaceutical manufacturing infrastructure and growing demand for advanced bioprocessing technologies. Brazil and Argentina are among the key markets.

Middle East & Africa is at an earlier stage of adoption but offers opportunities as governments invest in healthcare infrastructure, pharmaceutical localization, and biotechnology. Saudi Arabia, the UAE, Kuwait, and South Africa are among the markets attracting increasing attention. 

Key Industry Players

The competitive landscape includes Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Danaher Corporation, Avantor, Lonza, Saint-Gobain, Corning Incorporated, Entegris, and KUHNER AG. These companies are focusing on product development, manufacturing expansion, strategic partnerships, customized solutions, and improvements in single-use bioprocessing technologies. 

Recent developments include SaniSure's introduction of Fill4Sure in April 2024, Getinge's agreement to acquire Purity New England in May 2023, Merck KGaA's launch of Ultimus single-use process container film in April 2023, and Thermo Fisher Scientific's development of a new single-use manufacturing site in Utah as part of its USD 650 million multi-year expansion plan.